Cartesian Therapeutics Inc. (RNAC) — Strategic Asset Allocation Index
Cartesian Therapeutics Inc. (RNAC) has a Strategic Asset Allocation Index of 266.0% as of September 2024. Strategic assets (PP&E of $- plus long-term investments of $2.00 Million) total $2.00 Million, measured against net assets of $752.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Cartesian Therapeutics Inc. Strategic Asset Allocation Index (2016–2022)
This chart shows how Cartesian Therapeutics Inc.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2016 to 2022. As of September 2024, the index stands at 266.0%, representing strategic assets of $2.00 Million against net assets of $752.00K USD. Explore RNAC cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Cartesian Therapeutics Inc. (2016–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Cartesian Therapeutics Inc. from 2016 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see market cap of Cartesian Therapeutics Inc..
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 5.1% | $4.79 Million | $2.79 Million | $2.00 Million | $93.83 Million | ▼ -13.3 pp |
| 2021 | 18.4% | $4.14 Million | $2.14 Million | $2.00 Million | $22.52 Million | ▲ +0.3 pp |
| 2019 | 18.1% | $1.52 Million | $1.52 Million | $- | $8.40 Million | ▲ +14.1 pp |
| 2017 | 4.0% | $2.09 Million | $2.09 Million | $- | $51.81 Million | ▲ +0.3 pp |
| 2016 | 3.7% | $2.05 Million | $2.05 Million | $- | $54.96 Million | — |